The Effect of SLC19A3 Inhibition on the Pharmacokinetics of Thiamine
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
This PHASE4 trial investigates Thiamine Deficiency and Vitamin B1 Deficiency and is currently completed. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) leads this study, which shows 14 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Feb 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Feb 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Sep 2023 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Jun 2023 — Sep 2023 [monthly]
Recruiting PHASE4
▶ Show 9 earlier versions
-
Jan 2023 — Jun 2023 [monthly]
Recruiting PHASE4
Status: Unknown Status → Recruiting
-
Nov 2022 — Jan 2023 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jan 2021 — Nov 2022 [monthly]
Recruiting PHASE4
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Apr 2020 — Nov 2020 [monthly]
Recruiting PHASE4
-
Dec 2019 — Apr 2020 [monthly]
Recruiting PHASE4
-
Mar 2019 — Dec 2019 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jan 2019 — Mar 2019 [monthly]
Not Yet Recruiting PHASE4
-
Dec 2018 — Jan 2019 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Tufts University
- University of California, Davis
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .